Narmada Gelatines Ltd Valuation Shifts Signal Attractive Investment Opportunity

Valuation Metrics and Recent Changes

As of 17 Sep 2026, Narmada Gelatines trades at a price of ₹452.30, down 1.94% from the previous close of ₹461.25. The stock’s 52-week range spans from ₹327.30 to ₹545.00, indicating a moderate volatility band. The company’s price-to-earnings (P/E) ratio currently stands at 7.86, a slight decrease from the peer-comparison figure of 8.65, reflecting a valuation that remains attractive relative to its industry cohort.

The price-to-book value (P/BV) ratio is 1.94, suggesting the stock is trading at nearly twice its book value, which is reasonable for a specialty chemicals firm with strong return metrics. Other valuation multiples such as EV/EBIT (6.62), EV/EBITDA (6.18), and EV to capital employed (1.89) further reinforce the company’s cost-effective valuation, especially when benchmarked against peers.

Peer Comparison Highlights

When compared with key competitors, Narmada Gelatines’ valuation stands out for its relative affordability. For instance, J.G. Chemicals, another specialty chemicals player, trades at a P/E of 30.34 and EV/EBITDA of 22.22, while Titan Biotech is classified as very expensive with a P/E of 49.61 and EV/EBITDA of 39.77. Oriental Aromatics and Indo Borax & Chemicals also command significantly higher multiples, underscoring Narmada’s attractive valuation position.

Even within the attractive valuation bracket, Narmada Gelatines compares favourably with TGV Sraac, which has a P/E of 7.94 and EV/EBITDA of 3.83. This peer group analysis highlights that while Narmada’s multiples are slightly higher than the lowest in the segment, they remain well below the sector’s expensive and very expensive stocks, offering a balanced risk-reward profile.

Strong Profitability and Growth Indicators

Beyond valuation, Narmada Gelatines boasts impressive profitability metrics. The company’s return on capital employed (ROCE) is 25.78%, and return on equity (ROE) stands at 22.40%, both indicative of efficient capital utilisation and shareholder value creation. The dividend yield of 2.43% adds an income component to the investment thesis, enhancing total returns for shareholders.

Its PEG ratio of 0.12 is particularly noteworthy, signalling that the stock is undervalued relative to its earnings growth potential. This low PEG ratio contrasts sharply with peers like J.G. Chemicals (1.85) and Titan Biotech (0.92), suggesting that Narmada Gelatines offers growth at a bargain valuation.

Stock Performance Relative to Sensex

Examining Narmada Gelatines’ stock returns relative to the Sensex reveals a strong outperformance over longer time horizons. Year-to-date, the stock has delivered a robust 30.99% gain, significantly outpacing the Sensex’s negative 12.77% return. Over one year, the stock returned 21.64% compared to the Sensex’s -9.76%, and over five years, it has surged 129.89% against the benchmark’s 25.69%.

However, shorter-term performance has been more subdued, with a one-month decline of 8.06% versus the Sensex’s 4.71% drop, and a one-week fall of 3.61% compared to the index’s 0.57% loss. This recent weakness may reflect broader market volatility or sector-specific pressures but does not detract from the company’s strong medium- to long-term growth trajectory.

Valuation Grade Revision and Market Sentiment

MarketsMOJO recently revised Narmada Gelatines’ mojo grade from Strong Buy to Buy on 11 Aug 2026, reflecting the shift in valuation grade from very attractive to attractive. This adjustment signals a maturing valuation profile as the stock price has appreciated, yet it remains a favourable entry point for investors seeking exposure to the specialty chemicals sector.

The company’s mojo score of 71.0 supports this positive stance, indicating solid fundamentals and a healthy risk-reward balance. As a micro-cap stock, Narmada Gelatines offers growth potential but also carries inherent liquidity and volatility risks, which investors should weigh carefully.

Investment Outlook and Considerations

Investors evaluating Narmada Gelatines should consider the company’s strong return ratios and attractive valuation multiples as key positives. The stock’s P/E ratio of 7.86 is well below the industry average, and its PEG ratio of 0.12 suggests undervaluation relative to earnings growth. These factors, combined with a dividend yield of 2.43%, make the stock appealing for value-oriented and income-focused investors alike.

However, the recent downgrade from Strong Buy to Buy indicates that the valuation cushion has narrowed, and the stock price has factored in much of the company’s growth prospects. The micro-cap status also implies higher volatility and lower liquidity compared to larger peers, which may not suit all investors.

Comparatively, peers such as J.G. Chemicals and Titan Biotech trade at significantly higher multiples, reflecting either stronger growth expectations or market premium for scale and diversification. Narmada Gelatines’ niche focus in specialty chemicals and efficient capital deployment underpin its competitive advantage but also expose it to sector cyclicality and raw material price fluctuations.

Overall, the shift in valuation grade from very attractive to attractive should be viewed as a positive evolution, signalling that the stock remains a compelling buy but with a more balanced risk-reward profile than before.

Conclusion

Narmada Gelatines Ltd presents a strong case for investors seeking exposure to the specialty chemicals sector at an attractive valuation. The company’s robust profitability, low valuation multiples relative to peers, and impressive long-term stock performance underscore its investment appeal. While recent price softness and a slight downgrade in mojo grade suggest caution, the overall fundamentals remain solid.

For investors willing to accept micro-cap risks, Narmada Gelatines offers a well-rounded package of growth potential, reasonable valuation, and dividend income. Monitoring the company’s operational performance and sector dynamics will be crucial to capitalising on this opportunity as it unfolds.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today